| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |